Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 46 Foreign Institutions (11.63%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
102 Million
(Quarterly Results - Jun 2023)
Net Profit:
4 Million
Pharmaceuticals & Biotechnology
ILS 232 Million ()
7.00
NA
0.00%
0.24
8.58%
0.54






